GlassScriptPhysician profile
Shauna Kroll
NPI 1114460151
$1,682.12
in general payments reported to CMS, 2019-2025
19 companies · $821 in 2025
The $821 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.81 · 2024: $846 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.46 |
| Education | $180.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $265.35 | 2025 | Nemluvio |
| Janssen Biotech, INC. | $264.68 | 2024-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $224.44 | 2024-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $155.97 | 2024-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $150.02 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Dermavant Sciences, INC. | $82.17 | 2024 | Vtama |
| Incyte Corporation | $80.49 | 2024 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $70.30 | 2024 | Jublia |
| Amgen INC. | $62.76 | 2025 | Otezla |
| Abbvie INC. | $59.01 | 2024 | |
| Ucb, INC. | $45.16 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $37.88 | 2024 | |
| Sun Pharmaceutical Industries INC. | $37.37 | 2025 | |
| Biofrontera INC. | $34.54 | 2025 | |
| Organon LLC | $31.34 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $27.09 | 2024 | |
| Arcutis Biotherapeutics, INC. | $19.58 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $18.16 | 2024 | Saphnelo |
| Bioventus LLC | $15.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shauna Kroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.